Advertisement
Person › Details
Eszter Nagy (Arsanis Biosciences GmbH)
Nagy, Eszter (Arsanis 201010– CSO + Co-founder before SVP Research at Intercell AG)
Organisation | Arsanis Biosciences GmbH | |
Group | Arsanis (Group) | |
Product | therapeutic antibody | |
Product 2 | anti-infective drug | |
Record changed: 2020-03-08 |
Advertisement
More documents for Eszter Nagy
- [1] Calyxha Biotechnologies GmbH. (3/4/20). "Press Release: Calyxha Endeavors to Develop Novel Approaches to Tissue Degenerative Diseases and Receives Support from Austrian VC and International Investors". Vienna....
- [2] Arsanis, Inc.. (4/20/17). "Press Release: Arsanis Announces Initial Clinical Data for ASN100 to be Presented at the 27th European Congress of Clinical Microbiology and Infectious Diseases". Waltham, MA & Vienna....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top